SCHEMBL5306262

SCHEMBL5306262

NC(=O)C1CCN(CCCS(=O)(=O)N2CCNCC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 1/20 0.46
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 2/20 0.40
DRD2 P14416 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
ALOX15 P16050 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
IKBKB O14920 4/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPK1 P28482 1/20 0.36
HIF1A Q16665 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMYD3 Q9H7B4 1/20 0.35
NPC1 O15118 1/20 0.35
GNAI3 P08754 2/20 0.35
GNAO1 P09471 2/20 0.35
GNAI1 P63096 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5212302 0.85 SMN1; SMN2 (0.50) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL5215761 0.84 ALOX15 (0.52) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL5216679 0.83 SMN1; SMN2 (0.49) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL5215957 0.83 SMN1; SMN2 (0.60) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL5214681 0.83 HTR4 (0.46) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL5306266 0.81 HTR4 (0.47) HTR4GNAI3GNAO1GNAI1
SCHEMBL5217099 0.81 HTR4 (0.48) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL5219357 0.80 HTR4 (0.50) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL5216773 0.80 SMN1; SMN2 (0.42) HTR4ALDH1A1GAASMN1; SMN2LMNA
SCHEMBL27748790 0.77 ALDH1A1 (0.51) ALDH1A1GAASMN1; SMN2LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1112270-B1 DIHYDROBENZODIOXINE CARBOXAMIDE AND KETONE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2007-03-21 EP disclosed